Novo Nordisk continues victory dance with Victoza
This article was originally published in Scrip
Executive Summary
The world's biggest insulin maker, Novo Nordisk, has raised its 2012 sales and profits forecasts following a 22% increase in net profit to DKK10.01 billion ($1.65 billion).